10.03 for one tablet Mankind Pharma IPO: The issue, which is an offer for sale, is expected to fetch the pharma company's shareholders Rs 4,326.36 crore at the upper end of the price band of Rs ...
Rajeev Juneja, managing director of Mankind Pharma, shared his thoughts on collaborating with new celebrity faces like ...
Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.
Below are some trading ideas for the near term. Buy Mankind Pharma; target of Rs 3050: Motilal Oswal Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a ...
The company has received an order on January 14, 2025 from Office of the Commissioner of Kolkata South CGST & CX -- issued by Additional Commissioner, Mankind Pharma said in a regulatory filing.
Seamless reading experience. Save your favourite. Mankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix of ...
Mankind Pharma Ltd on Wednesday said it has been imposed a GST related penalty of over Rs 2 crore by tax authority in Kolkata over alleged mismatch in figures for the period of FY18 to FY22.
Earnings worries yank Indian shares to third week of losses January 24, 2025 India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in expenses.